• Company Type For Profit
  • Phone Number 6172091729

Founded in 2007, InaVein's mission is to develop and commercialize a family of innovative products to treat the full spectrum of vein disorders. The TRIVEX System uses a direct visualization technique to completely remove varicose veins in a shorter period of time compared to conventional phlebectomy procedures. The TCI (Tumescent Catheter

Inversion) System provides a device to quickly remove the Greater Saphenous Vein with less trauma and pain. The TES (Tumescent Enhanced Sclerotherapy) System provides a convenient method to more effectively treat spider veins. Together these three products represent our innovative efforts to advance vein therapies.

Lists Featuring This Company

Closed New England Companies
4,876 Number of Organizations • $45.5B Total Funding Amount • 5,336 Number of Investors
Companies That Exited in 2013
6,894 Number of Organizations • $186.4B Total Funding Amount • 5,188 Number of Investors
Closed Greater Boston Area Companies
3,223 Number of Organizations • $34.7B Total Funding Amount • 4,552 Number of Investors
New England Companies that Exited
6,656 Number of Organizations • $341.7B Total Funding Amount • 11,001 Number of Investors
Inavein was acquired by LeMaitre Vascular for $2.5M on Aug 28, 2013.

Frequently Asked Questions

Where is Inavein's headquarters? Inavein is located in Lexington, Massachusetts, United States.